The US Bankruptcy Court gave an order approving the sale of certain assets of Pear Therapeutics, Inc. on May 23, 2023. The debtor has been authorized to sell its certain assets to Harvest Bio LLC for a purchase price of $2.03 million in cash plus assumption of the assumed liabilities plus any cure costs. The debtor’s assets include Invention Science Fund licenses and patents, schizophrenia (Pear-004), multiple sclerosis and depression (Pear-006), major depressive disorder, other pipeline assets, corporate trademarks, PearConnect, and reSET® and reSET-O®.